Alta Sciences

JANUARY 22, 2024

Get a Head Start On Your 2024 Preclinical Drug Development Program blussier Mon, 01/22/2024 - 15:18 HTML EXPERTISE Matters. With four strategically placed preclinical research facilities throughout North America, Altasciences can get your CTA/IND-enabling studies underway in just 8 weeks!

Drug Development 40

Drug Development Clinical Trials Drugs Trials 40

LifeSciVC

JANUARY 16, 2024

Whether trial design, execution, or otherwise, drug development even where there is precedent is a challenging road and should not be taken for granted. Additional trials (e.g., The incretins as a class also look interesting across a number of follow-on indications, as evidenced by clinical trials in these areas (below).

Small Molecule 139

Small Molecule Trials Therapies Disease 139

Drug Discovery World

JANUARY 2, 2024

Cancer Research Horizon’s Innovation Summit 2023 took place on 21 November 2023 at the Royal Society of Medicine, and included talks from researchers translating their research, as well as networking with members of the entrepreneurial ecosystem. As for Infinitopes, the company’s trials will begin in 2024.

Research 148

Research Vaccine Science Trials 148

Fierce BioTech

MARCH 12, 2024

Listing Image PPD-TF-logo.png Listing Introduction Get the latest FSP trends, strategies, and projections for biopharma and biotech companies as Lori Boyce, Vice President, PPD FSP Solutions, and Mike Lydon, Director, PPD FSP Solutions, share findings from The 2024 FSP Trends Report. On Demand Start Date Thu, 04/11/2024 - 12:00

Clinical Research 52

Clinical Research Drug Development Trials Research 52

Drug Discovery World

FEBRUARY 16, 2024

DDW recently hosted an online event, sponsored by Taconic Biosciences, which outlined areas of advancement and opportunity in the cancer research market. New drug discovery and development concepts The event started with a panel discussion on new drug discovery and development concepts and tools in cancer research.

Science 130

Science Research Vaccine Production 130

Perficient: Drug Development

JANUARY 9, 2024

Medical device industry trends for 2024. Let’s look at what is poised to impact the medical device industry in 2024. Let’s look at what is poised to impact the medical device industry in 2024. The medical device industry is in a constant state of evolution. population will be 65 and older by the year 2060.

Production 110

Production Clinical Trials Marketing Trials 110

PPD

MARCH 28, 2024

Through the first few months of 2024, the economic landscape is showing signs of returning to a semblance of normalcy, mirroring the pre-COVID era. According to Jeffries Equity Research, funding totals exceeded $15 billion in January and February, marking the best monthly tallies in over a year.

Trials 52

Trials Clinical Trials Drug Development Clinical Research 52

Vial

MAY 20, 2024

Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research Randomized clinical trials are the gold-standard of evidence-based medicine, representing the culmination of the long, arduous drug development pipeline. What is a Pre-Clinical CRO? billion in 2022 and is projected to reach US$10.2

Clinical Research 52

Clinical Research Research Clinical Trials Laboratories 52

Alta Sciences

JANUARY 15, 2024

How Is Your CRO Handling Your Trial Data? We highlight best practices and approaches to mitigate challenges, and show how integration and collaboration build the strongest datasets for your drug development program. ACCESS THIS ISSUE Speak with an expert to learn more about our service offering. Have a few more minutes?

Trials 52

Trials Clinical Trials Drug Development Research 52

Perficient: Drug Development

FEBRUARY 1, 2024

The conference will take place on February 11-14, 2024, in Orlando, Florida. The SCOPE (Summit for Clinical Ops Executives) conference is a premier event in the field of clinical operations, providing a comprehensive platform for professionals to explore the latest trends and innovations in clinical research. Still not registered?

Science 59

Science Clinical Research Clinical Trials Trials 59

Alta Sciences

JANUARY 11, 2024

Regulatory Comparisons for Starting First-In-Human Clinical Trials sdubois Thu, 01/11/2024 - 12:43 Publication EU UK Regulatory Comparison_eBook_v5_0.pdf pdf Tags Clinical Trials Preclinical Research Regulatory Affairs Outsourcing Drug Development Category eBook Weight 1

Clinical Trials 40

Clinical Trials Trials Drug Development Research 40

Agency IQ

JULY 8, 2024

What we expect European regulators to do in July 2024 In this recurring feature, AgencyIQ, through public data and previous analysis, determines what European medicine and device regulators will likely do in the month ahead, including key deadlines, meetings, events, planned regulations, comment periods, and more. and national regulators.

Regulations 40

Regulations Pharmaceuticals Production Compliance 40

Vial

FEBRUARY 8, 2024

To advance new therapies, pharmaceutical, biotech, and medical device companies engage contract research organizations (CROs) for their know-how in navigating the complex landscape of drug development and regulatory pathways and to run clinical trials.

Clinical Trials 52

Clinical Trials Trials Clinical Research Research 52

Drug Discovery World

MAY 6, 2024

billion on R&D during 2021, with Germany and Switzerland being the biggest contributors, and around one fourth of clinical trials worldwide were performed in Europe 1. Even before this, however, Amsterdam was established as an important centre for drug development. The CDD will sponsor and manage KWF-supported trials.

Drugs 148

Drugs Science Molecular Biology Clinical Trials 148

Conversations in Drug Development Trends

JULY 9, 2024

Due to this meaningful change, the first-ever GLP-1-Based Therapeutics Summit took place in Philadelphia on May 15-16th, 2024, serving as a platform for industry decision-makers to provide invaluable insights for therapeutic strategies.

Clinical Research 52

Clinical Research Treatment Research Clinical Trials 52

Agency IQ

MAY 3, 2024

What We Expect the FDA to do in May and June 2024 In this ongoing feature, AgencyIQ looks at public data to determine what the FDA is likely to do in the months ahead, including key deadlines, meetings, events, planned regulations, comment periods and more.

FDA 40

FDA Science Regulations Clinical Trials 40

Alta Sciences

FEBRUARY 8, 2024

President of Cognitive Research Corporation , examine simple and cognitive domains in clinical and pharmacology studies, including analysis of driving impairment. Tags Clinical Trials Weight 12 In this on-demand webinar, Ingrid Holmes , Vice President of Global Clinical Operations at Altasciences, and Dr. Gary G.

Clinical Trials 52

Clinical Trials Trials Clinical Pharmacology Clinical Development 52

Drug Discovery World

JANUARY 8, 2024

The first clinical-trial results for the compound are expected this year. New antibiotics directed against the world’s highest priority bacteria, like Acinetobacter baumannii , require novel development paths. Unlike broad-spectrum antibiotics, the potential new antibiotic is specific to carbapenem-resistant A.

Clinical Trials 130

Clinical Trials Government Drugs Trials 130

Agency IQ

APRIL 19, 2024

Meet C3TI, FDA’s new clinical trial innovation hub On April 14, FDA announced that its Center for Drug Evaluation and Research (CDER) is launching a new clinical trial innovation hub, the CDER Center for Clinical Trial Innovation (C3TI). In particular, regulations in both the U.S.

Clinical Trials 40

Clinical Trials Trials Science FDA 40

Alta Sciences

JUNE 21, 2024

Simpler Clinical Development From Day Dot blussier Fri, 06/21/2024 - 19:10 HTML Connecting the Dots With Comprehensive CRO Solutions When you CONNECT THE DOTS, you open a world of possibilities. With you in mind, we establish a clear and consistent path from drug discovery to delivery—one solution seamlessly connecting to the next.

Clinical Development 52

Clinical Development Clinical Trials Clinical Research Drug Development 52

PPD

JANUARY 5, 2023

In an industry survey led by PPD, Thermo Fisher Scientific’s clinical research business, rare diseases emerged as a top therapeutic area in drug developers’ pipelines, with 39% of global biotech and biopharma leaders pursuing therapies in the broad rare disease space.

Disease 52

Disease Trials Clinical Trials Clinical Research 52

Conversations in Drug Development Trends

DECEMBER 7, 2023

Amidst a shifting clinical landscape characterized by increasingly complex trial designs and growing patient subpopulations, many contract research organizations (CROs) have adopted a “one-stop-shop” strategic approach. What Differentiates Mid-Size CROs?

Clinical Trials 136

Clinical Trials Clinical Development Trials Pharmaceutical Companies 136

Agency IQ

MARCH 1, 2024

What We Expect the FDA to do in March and April 2024 In this ongoing feature, AgencyIQ looks at public data to determine what the FDA is likely to do in the months ahead, including key deadlines, meetings, events, planned regulations, comment periods and more.

FDA 40

FDA Science Clinical Trials Regulations 40

Drug Discovery World

JANUARY 30, 2024

Lentivirus strategies are one of the most widely used tools in biomedical research and clinical testing, says Stella Vnook, CEO, Likarda. “Dr Streamlining trial designs and regulatory pathways can help. Developing financial assistance programs and exploring alternative funding models are important.

Therapies 180

Therapies Clinical Trials Trials Production 180

Drug Discovery World

JANUARY 19, 2024

BPGbio, an AI-powered biopharma that focuses on oncology, neurology, and rare diseases, has announced new data from a Phase IIa clinical trial of its lead candidate, BPM31510, in patients with advanced pancreatic cancers at the annual ASCO Gastrointestinal Cancers Symposium, being held 18-20 January 2024, in San Francisco.

Therapies 130

Therapies Clinical Trials Trials Treatment 130

Agency IQ

FEBRUARY 2, 2024

What We Expect the FDA to do in February and March 2024 (Updated) In this ongoing feature, AgencyIQ looks at public data to determine what the FDA is likely to do in the months ahead, including key deadlines, meetings, events, planned regulations, comment periods and more.

FDA 40

FDA Science Clinical Trials Regulations 40

Alta Sciences

JULY 10, 2024

Inside The Altascientist: Nonclinical Dermal Study Considerations pmjackson Wed, 07/10/2024 - 15:25 An increasing number of advanced methods for dermal drug delivery contribute to successful 505(b)(2) applications and extend the patent life of a drug for its sponsor.

Compliance 52

Compliance Clinical Trials Trials Drug Development 52

Drug Discovery World

APRIL 23, 2024

Valera, an Associate Professor of Psychiatry at Harvard University and a leading researcher on traumatic brain injuries among survivors of domestic violence, estimated that while hundreds of concussions occur in the NFL each year, there could be nearly 1.6 There are a number of companies currently developing concussion drug therapies.

Therapies 148

Therapies Drugs Laboratories Medical Schools 148

Drug Discovery World

FEBRUARY 13, 2024

Often this can be drug approvals, exciting research into hard-to-treat indications, or even regulatory updates that enable players within the sector to utilise the latest technologies and drive therapies to market faster, ultimately benefitting patients. But is AI the answer to the industry’s development challenges?

Small Molecule 148

Small Molecule Drugs Therapies Pharmaceutical Companies 148

Alta Sciences

FEBRUARY 19, 2024

Altasciences Has You Covered From Coast to Coast blussier Mon, 02/19/2024 - 22:01 HTML Altasciences Has You Covered From Coast to Coast Accelerate your drug development timelines by up to 40% with an integrated CRO/CDMO by your side, from lead candidate selection to clinical proof of concept, and beyond.

Clinical Trials 52

Clinical Trials Drug Development Trials Research 52

PPD

MARCH 26, 2024

The PPD clinical research business of Thermo Fisher Scientific conducts an annual survey of more than 150 leaders at pharmaceutical companies around the globe to assess trends in drug discovery and development, including preferences around outsourcing and functional service provider (FSP) utilization.

Pharmaceutical Companies 98

Pharmaceutical Companies Clinical Research Clinical Development Drug Development 98

Drug Discovery World

SEPTEMBER 26, 2023

Throughout the report, the personal stories of patients who have benefited from innovative, recently approved anticancer therapeutics highlight the real-world impact of cancer research. The advances in cancer research, particularly in the last two decades, have been breathtaking,” said AACR President Philip Greenberg, MD, FAACR. “We

Clinical Trials 130

Clinical Trials Science FDA FDA Approval 130

Drug Discovery World

JUNE 20, 2024

Deepika Khedekar investigates the use of LLMs in clinical trials and how we can overcome the potential challenges to their wider application. billion 1 is the estimated cost of bringing a new drug from the drawing board to pharmacy shelves today. Clinical trials make up a large part of this investment, and yet 95% of them fail 2.

Clinical Research 148

Clinical Research Research Clinical Trials Trials 148

Drug Discovery World

FEBRUARY 9, 2023

Launched in 2020, the Oxford-based business hopes the designation will “open regulatory discussions, supplement funding, increase the viability of drug development and enable quick access to market a treatment.” SynaptixBio CEO and co-founder Dr Dan Williams said the designation was a “monumental step forward” in its bid to treat the disease.

Treatment 130

Treatment Disease Clinical Trials FDA 130

Drug Discovery World

JUNE 7, 2023

Hosted by DDW and sponsored by DNA Script, join us for this free-to-attend roundtable to learn about the biggest opportunities for the future of drug discovery and development. Panellists will discuss the following questions: Where will the opportunities be in 2024? What changes can we expect from clinical trials?

DNA 130

DNA Clinical Trials Drugs Vaccine 130

Conversations in Drug Development Trends

JUNE 21, 2024

The 2024 ASCO Annual Meeting from the American Society of Clinical Oncology is a fantastic platform for clinical researchers to discuss the latest advancements and challenges in oncology research. Biomarker Development : Identifying predictive biomarkers can help classify patients based on safety and efficacy profiles.

Clinical Trials 64

Clinical Trials Clinical Research Immune Response Therapies 64

Drug Discovery World

JUNE 27, 2023

Join this free roundtable to learn about the biggest opportunities for the future of drug discovery and development. Roundtable panelists include Commercial Research Scientist Dr Mark Treherne, CEO of Elevation Oncology, Joe Ferra, and CEO of BioXcel Therapeutics, Vimal Mehta. What changes can we expect from clinical trials?

DNA 130

DNA Clinical Trials Drugs Vaccine 130